Clinical TrialID 8272

Efficacy of Lauric Acid, a Dietary Fatty Acid, in Modifying the Latent Reservoir of HIV

NCT05687565

HIV Infections

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
8272
Evidence Id
8272
Core Evidence Id
8272
Source Clinical Trial Id
8270
Herb2 Clinical Trial Id
HBCT008270
Nct Id
NCT05687565
Title
Efficacy of Lauric Acid, a Dietary Fatty Acid, in Modifying the Latent Reservoir of HIV
Status
Recruiting
Phase
Study Result
No
Study Condition
HIV Infections
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Intervention
DIETARY_SUPPLEMENT: Control group placebo|DIETARY_SUPPLEMENT: Experimental group 1 lauric acid|DIETARY_SUPPLEMENT: Experimental group 2 lauric acid
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Single
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
27
Outcome Measure
Effective of lauric acid in HIV, Number of patients on a lauric acid diet presenting a response on the reactivation of HIV transcription in CD4 T cells., 48 weeks
Sponsor Collaborator
Hospital Universitari Vall d'Hebron Research Institute
Funded By
OTHER
Location
Hospital Universitario Vall d“Hebron, Barcelona, 08035, Spain
Other Id
PR(AG)12/2022
Start Date
2022-09-27
Primary Completion Date
2025-11-21
Completion Date
2025-12-21
First Posted
2023-01-18
Results First Posted
Last Update Posted
2023-01-18
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05687565
Title Cn
Title En
Efficacy of Lauric Acid, a Dietary Fatty Acid, in Modifying the Latent Reservoir of HIV
Bilingual Status
semi_complete